Related Experiment Video

Updated: Jul 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Role of p53 and CDKN2A inactivation in human squamous cell carcinomas

Alessia Pacifico1, Giovanni Leone

  • 1Phototherapy Unit, San Gallicano Dermatological Institute-IRCCS, 00144 Rome, Italy.

Journal of Biomedicine & Biotechnology
|June 2, 2007
PubMed

Insights

The p53 tumor suppressor gene is frequently mutated in cancers. Silencing of the CDKN2A gene, alongside p53 mutations, may significantly contribute to the development of squamous cell carcinoma (SCC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor gene is the most frequently mutated gene in human and mouse cancers.
  • Disruption of the p53 and Rb pathways is a hallmark of many human cancer cells.
  • Inactivation of the CDKN2A gene can lead to the deregulation of these critical pathways.

Purpose of the Study:

  • To investigate the role of the CDKN2A gene in human nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC).
  • To clarify the involvement of genetic abnormalities in CDKN2A in SCC, as opposed to its well-documented role in melanoma.

Main Methods:

  • Analysis of genetic abnormalities in the CDKN2A gene in human SCC samples.
  • Comparison of mutation patterns in CDKN2A and p53 genes in relation to UV radiation exposure.

Main Results:

  • Human SCCs exhibit unique mutations in the p53 gene and inactivation of the CDKN2A gene.
  • While p53 mutations in SCC are UV-induced and initiate tumors, CDKN2A alterations are largely independent of UV radiation.
  • Genetic abnormalities in CDKN2A appear distinct from UV-induced damage.

Conclusions:

  • Silencing of the CDKN2A gene is implicated as a significant factor in the development of squamous cell carcinoma (SCC).
  • In addition to p53 mutations, CDKN2A inactivation plays a crucial role in SCC pathogenesis, suggesting potential therapeutic targets.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.